A major problem in the pathogenesis of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection is that angiotensin-converting enzyme 2 (ACE2), within the renin-angiotensin-aldosterone system (RAAS), fails to fulfill its physiological roles following viral interaction (1–5). Here, ACE2 is linked to COVID-19.